Related Experiment Videos
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients
M Ramanathan1, B Weinstock-Guttman, L T Nguyen
1Department of Pharmaceutics, 543 Cooke Hall, State University of New York at Buffalo, 14260-1200, Buffalo, NY, USA. murali@acsu.buffalo.edu
Journal of Neuroimmunology
|July 5, 2001
Summary
DNA arrays revealed distinct gene expression patterns in relapsing-remitting multiple sclerosis (RRMS). Key inflammatory and immune genes showed altered expression, offering insights into RRMS pathogenesis.
Area of Science:
- Genomics
- Immunology
- Neuroscience
Background:
- Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
- Relapsing-remitting MS (RRMS) is the most common form, characterized by distinct neurological episodes.
- Understanding the molecular underpinnings of RRMS is crucial for developing targeted therapies.
Purpose of the Study:
- To identify differences in gene expression associated with relapsing-remitting multiple sclerosis (RRMS) using DNA arrays.
- To investigate the molecular pathways potentially involved in RRMS pathogenesis.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) were isolated from 15 RRMS patients and 15 matched controls.
- RNA was extracted, converted to cDNA, and hybridized to a DNA array containing over 4000 human genes.
- Gene expression levels were quantified using phosphorimaging.
Main Results:
- Out of over 4000 genes, 34 showed significant differential expression in RRMS patients compared to controls.
- Twenty-five genes were upregulated and nine were downregulated in RRMS patients.
- Twelve of these differentially expressed genes possess inflammatory or immunological functions relevant to MS.
Conclusions:
- The impact of RRMS on gene expression is relatively specific, affecting a subset of genes.
- Significant alterations in inflammatory and immune-related gene expression were identified in RRMS.
- DNA arrays provide valuable insights into the dynamic cellular pathways and heterogeneity of MS.